Astrana Health (ASTH) Net Equity Issued and Repurchased (2016 - 2021)

Astrana Health has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $1000.0 in Q4 2021.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2021 was -$1000.0 (up 99.87% YoY) and the FY2021 annual result came in at $40.1 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased rose to $1000.0 in Q4 2021 per ASTH's latest filing, from -$1000.0 in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $2.0 million in Q4 2017 and troughed at -$755000.0 in Q4 2019.
• A 4-year average of $270092.0 and a median of $102500.0 in 2019 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 75.0% in 2019, down 75.0% in 2019.
• Over 4 years, Net Equity Issued and Repurchased stood at $2.0 million in 2017, then plunged by 89.8% to $200000.0 in 2018, then tumbled by 477.5% to -$755000.0 in 2019, then jumped by 100.13% to $1000.0 in 2021.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1000.0, -$1000.0, and -$755000.0 for Q4 2021, Q3 2021, and Q4 2019 respectively.